Access Resources
2941 - 2950 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 182End Page: 192Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30489-0Best OA location URL: http://www.thelancet.com/article/S1474442220304890/pdfCitation Count: 73
-
RESTRICTEDTitle: Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.020Best OA location URL: http://www.prd-journal.com/article/S1353802021000110/pdfCitation Count: 9
-
RESTRICTEDTitle: Skin conditions in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 40End Page: 46Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900714Citation Count: 1
-
RESTRICTEDTitle: StoCast: Stochastic Disease Forecasting With Progression UncertaintyJournal Name: IEEE Journal of Biomedical and Health InformaticsPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 25Issue #: 3Start Page: 850End Page: 861Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/jbhi.2020.3006719Citation Count: 9
- Study of functional connectivity of central motor system in Parkinson’s disease using copula theory2021RESTRICTEDTitle: Study of functional connectivity of central motor system in Parkinson’s disease using copula theoryJournal Name: Biomedical Signal Processing and ControlPublisher: Elsevier BVVol: 65Issue #:Start Page: 102320End Page: 102320Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bspc.2020.102320Citation Count: 9
-
RESTRICTEDTitle: Targeting β-Arrestins in the Treatment of Psychiatric and Neurological DisordersJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 3Start Page: 253End Page: 264Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-021-00796-yCitation Count: 8
-
RESTRICTEDTitle: The potential of biomaterials for central nervous system cellular repairJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 144Issue #:Start Page: 104971End Page: 104971Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuint.2021.104971Best OA location URL: https://doi.org/10.1016/j.neuint.2021.104971Citation Count: 18
-
RESTRICTEDTitle: The role of immune-mediated alterations and disorders in ALS diseaseJournal Name: Human ImmunologyPublisher: Elsevier BVVol: 82Issue #: 3Start Page: 155End Page: 161Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.humimm.2021.01.017Best OA location URL: https://doi.org/10.1016/j.humimm.2021.01.017Citation Count: 18
-
RESTRICTEDTitle: The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00162-1Best OA location URL: https://www.nature.com/articles/s41531-021-00162-1.pdfCitation Count: 9
-
RESTRICTEDTitle: TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respirationJournal Name: Cell ReportsPublisher: Elsevier BVVol: 34Issue #: 12Start Page: 108895End Page: 108895Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.108895Best OA location URL: http://www.cell.com/article/S2211124721002096/pdfCitation Count: 34